SCHEMBL6001382

SCHEMBL6001382

Fc1ccc(-c2cc(Cl)c3ccccc3n2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.60
TOP1 P11387 2/20 0.52
ESR1 P03372 2/20 0.51
ESR2 Q92731 2/20 0.51
ESRRB O95718 1/20 0.51
ESRRA P11474 1/20 0.51
DHODH Q02127 3/20 0.50
ACP1 P24666 3/20 0.50
ACHE P22303 1/20 0.49
ADORA2A P29274 1/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
ALDH1A1 P00352 1/20 0.47
HPGD P15428 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ABCG2 Q9UNQ0 1/20 0.47
KDM4E B2RXH2 3/20 0.46
POLB P06746 1/20 0.46
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30592743 0.88 DHODH (0.58) ESR1ESR2ESRRBESRRADHODH
SCHEMBL29793367 0.88 ACHE (0.61) ESR1ESR2ESRRBESRRADHODH
SCHEMBL785473 0.88 ACHE (0.61) ESR1ESR2ESRRBESRRADHODH
SCHEMBL6534331 0.86 NPC1 (0.54) ESR1ESR2ESRRBESRRADHODH
SCHEMBL10867068 0.85 ESR1 (0.61) CYP19A1TOP1ESR1ESR2ESRRB
SCHEMBL6534330 0.83 ALDH1A1 (0.60) ESR1ESR2ESRRBESRRADHODH
SCHEMBL10864863 0.83 DHODH (0.58) CYP19A1TOP1ESR1ESR2ESRRB
SCHEMBL5795122 0.83 ESRRB (0.51) ESR1ESR2ESRRBESRRADHODH
SCHEMBL8657096 0.83 TOP1 (0.63) CYP19A1TOP1DHODHACP1ACHE
SCHEMBL6534502 0.83 TOP1 (0.56) TOP1ESR1ESR2ESRRBESRRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060128702-A1 Heterocyclic and bicyclic compounds, compositions and methods REDDY US THERAPEUTICS, INC. 2006-06-15 US disclosed
EP-0168812-A1 4-Amino-2-phenyl quinolines, methods and intermediates for their preparation and medicaments containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1986-01-22 EP disclosed
US-4560692-A ANTICONVULSANTS OR ANXIOLYTIC AGENTS HOFFMANN-LA ROCHE INC. (US) 1985-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128702-A1 Heterocyclic and bicyclic compounds, compositions and methods HPSE, ENGASE, UGCG CYP19A1 863/4885TOP1 1469/4885ESR1 3209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.